mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.007 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.007 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |